Temporal Lobe Epilepsy Clinical Trial
Official title:
Regenerating the Adult Human Brain Through Exercise
Nearly 100 million Americans are affected by neurological disorders with an overall cost above $765 billion for the more prevalent conditions. Given this significant burden, effective treatments to prevent dementia and new disease modifying therapies are urgently needed. Regeneration of lost neurons with new ones (i.e., neurogenesis) is compromised at early stages of dementia and in part correlates with cognitive impairment in Alzheimer's disease. Boosting the neurogenesis delays the cognitive impairment in animal models of dementia and has been proven beneficial in improving the memory in rodent studies. Aerobic exercise is the most potent known stimulator of neurogenesis in animal models. A crucial next step is to translate endogenous regenerative strategies to people. The purpose of this study is to demonstrate the feasibility and investigate the effects of an exercise program on neurogenesis and cognitive improvement in epilepsy patients.
Status | Recruiting |
Enrollment | 10 |
Est. completion date | August 31, 2024 |
Est. primary completion date | August 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Age of 18 years or older - Medically resistant mesial temporal lobe epilepsy - Candidacy for standard or selective temporal lobectomy Exclusion Criteria: - Age of older than 65 years - Pregnancy - Physical disabilities or medical conditions preventing from participation in exercise program - Inability to receive exercise equipment at home - Cognitive/developmental disabilities restricting the participation in exercise program |
Country | Name | City | State |
---|---|---|---|
United States | University of Southern California Department of Neurosurgery | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
University of Southern California |
United States,
Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017 Apr;81(4):479-484. doi: 10.1002/ana.24897. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to exercise and assessments | Number of completed exercise and assessment sessions | Through study completion, an average of 6 months | |
Secondary | Neurogenesis | Number of new neurons per mm3 in surgically resected tissue after cell culture | 13 weeks after first exercise session | |
Secondary | Rey Auditory Verbal Learning Test (RAVLT) - Trial V | The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Trial V is the 5th attempt at recalling the first list of words. | Baseline and 12 weeks after first exercise session | |
Secondary | Rey Auditory Verbal Learning Test (RAVLT) - Summary score | The Rey Auditory Verbal Learning Test (RAVLT) is a validated test evaluating verbal learning and memory. In this test, lists of words are read to the participants in consecutive trials. Summary score is the sum of number of words learned over five learning trials. | Baseline and 12 weeks after first exercise session | |
Secondary | WAIS-IV - Matrix Reasoning | Wechsler Adult Intelligence Scale Fourth Edition (WAIS-IV) is a validated test of cognitive ability and intelligence. Matrix reasoning is among the tasks included in WAIS-IV which is used to assess non-verbal abstract problem solving and inductive reasoning. | Baseline and 12 weeks after first exercise session | |
Secondary | Rey Complex Figure Test (RCFT) | Rey Complex Figure Test (RCFT) is a standardized test of visuospatial memory. Performance will be scored based on the delayed recall trial of the RCFT. | Baseline and 12 weeks after first exercise session |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06269822 -
Autonomic Dysfunction in Temporal Lobe Epilepsy and SUDEP
|
||
Completed |
NCT05159609 -
Closed Loop Auditory Stimulus in Sleep and epilepsY
|
N/A | |
Completed |
NCT02946151 -
Subcutaneous EEG in Epilepsy
|
N/A | |
Not yet recruiting |
NCT02590419 -
Application of Diffusion Tensor Imaging and Tractography in Epilepsy Surgery
|
N/A | |
Completed |
NCT00595699 -
Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
|
Phase 4 | |
Recruiting |
NCT06466681 -
Changes in Attentional Control After a Focal Seizure.
|
||
Recruiting |
NCT05609084 -
Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy
|
N/A | |
Completed |
NCT00344877 -
Electrical Brain Stimulation to Reduce Epileptic Seizures
|
N/A | |
Not yet recruiting |
NCT05794295 -
Sleep Architecture & Intrinsic Oscillatory and Network Connectivity in Cognition and Executive Dysfunction in TLE
|
N/A | |
Recruiting |
NCT03643471 -
Advanced Magnetic Resonance Imaging in Temporal Lobe Epilepsy
|
||
Terminated |
NCT00717431 -
A Multicenter Study of Hippocampal Electrical Stimulation (HS, in Mesial Temporal Lobe Epilepsy
|
Phase 3 | |
Completed |
NCT02844465 -
Stereotactic Laser Ablation for Temporal Lobe Epilepsy
|
N/A | |
Recruiting |
NCT05019404 -
Minimally Invasive Surgical Epilepsy Trial for Temporal Lobe Epilepsy
|
N/A |